The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IL-12p40 and MIP3a to predict clinical responses to anti-PD-1 therapy in patients with metastatic melanoma.
 
Jesus Vera Aguilera
No Relationships to Disclose
 
Courtney L. Erskine
No Relationships to Disclose
 
Vera J. Suman
No Relationships to Disclose
 
Jonas Paludo
No Relationships to Disclose
 
Robert R. McWilliams
Consulting or Advisory Role - Merrimack (Inst); Zeno Pharmaceuticals
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
 
Lisa A. Kottschade
Consulting or Advisory Role - Array BioPharma; Eisenhower Health; Immunocore
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Yiyi Yan
No Relationships to Disclose
 
Roxana Stefania Dronca
Research Funding - Merck Sharp & Dohme (Inst)
Other Relationship - Elsevier
 
Haidong Dong
No Relationships to Disclose
 
Svetomir Markovic
Research Funding - Bristol-Myers Squibb; Seagen
 
Matthew Stephen Block
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Immune Design; Marker, Inc.; Merck; Pharmacyclics